Company intelligence / Profile preview

Repsol

Ownership: Public · REP
Employees: ~24000
Development stage: Other

Overview

Repsol is a global multi-energy and chemicals company that supplies over 30 grades of polyolefins (polypropylene, polyethylene [HDPE/LDPE], ethylene-vinyl acetate) under its Repsol Healthcare® brand for use in pharmaceutical packaging, diagnostics, and medical devices. These products comply with strict industry standards including GMP requirements. The company has also developed bio-based polyolefins targeting the medical/pharma sector with ISCC Plus certification[4][5][6][8].

Industry: Chemicals & Materials

Partnerships

DARWIN Bioprospecting Excellence (biotechnology collaboration/investment)

Financials

Market cap: $58.7M
Total revenue: $0

Beyond the preview

Go deeper on Repsol.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Repsol.

Explore the full profile